Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	33,349	38,323	55,558	36,109	28,508	59,346
Market Cap Growth	-50.57%	-31.02%	53.86%	26.67%	-51.96%	-
Enterprise Value	21,777	27,927	48,535	30,432	20,657	47,493
Last Close Price	63.60	73.89	-	-	-	-
PS Ratio	24.80	28.50	45.32	47.92	36.68	284.42
PB Ratio	1.64	1.88	2.58	4.61	3.01	5.33
P/TBV Ratio	2.81	3.23	4.85	5.70	3.02	5.35
EV/Sales Ratio	16.77	20.77	39.59	40.38	26.58	227.62
Debt / Equity Ratio	0.07	0.07	0.11	0.11	0.11	0.00
Net Debt / Equity Ratio	-0.59	-0.59	-0.47	-0.74	-1.03	-0.95
Net Debt / EBITDA Ratio	1.18	1.18	1.10	1.05	2.13	2.96
Net Debt / FCF Ratio	1.76	1.76	1.30	1.14	4.14	2.60
Asset Turnover	0.05	0.05	0.06	0.07	0.06	0.02
Quick Ratio	5.20	5.20	3.43	4.24	5.51	11.27
Current Ratio	5.50	5.50	3.81	4.70	5.68	11.46
Return on Equity (ROE)	-59.54%	-59.54%	-61.90%	-69.12%	-46.56%	-47.51%
Return on Assets (ROA)	-27.72%	-27.72%	-28.48%	-32.29%	-23.42%	-25.14%
Return on Capital Employed (ROCE)	-48.90%	-48.90%	-38.00%	-62.50%	-40.90%	-32.40%
Earnings Yield	-34.81%	-30.29%	-17.39%	-15.36%	-16.39%	-6.44%
FCF Yield	-20.42%	-17.77%	-13.98%	-14.03%	-8.25%	-6.85%
Buyback Yield / Dilution	-63.18%	-63.18%	-31.92%	-18.41%	-40.04%	-475.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.